pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 11·1 min read
save

Trump pushes controversial changes to MMR vaccine policy, eclipsing new food additive rule

Aug 11, 2026·read at STAT ↗RegulatoryNegative

President Trump has shifted the national conversation back to vaccine policy, calling for the measles‑mumps‑rubella (MMR) vaccine to be broken up into separate shots. The proposal has sparked immediate debate among health officials and lawmakers.

The announcement arrives just as the administration rolled out a new rule governing food additives, a measure that had previously been the focus of regulatory attention. The vaccine discussion now dominates media coverage, pushing the food rule into the background.

Senator Bill Cassidy expressed displeasure with the president’s stance, highlighting concerns that the move could undermine public health efforts. Critics argue that the policy shift distracts from broader health initiatives and may create confusion among the public.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Trump’s vaccine pivot overshadows food rule”

read at STAT ↗
409 words · retrieved Aug 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.
topics
Vaccine9Vaccines2mRNA TherapeuticmRNA Vaccine

related stories

  • Sep 145 drugmakers chasing Merck and Moderna in the cancer vaccine raceBioSpace
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace
  • Sep 8Inhibrx’s OX40 agonist add-on beats Keytruda alone in head and neck cancerBioSpace
  • Sep 8Moderna and Merck’s mRNA success fuels focus on ‘scaling out and scaling down’BioSpace
  • Sep 2Teva claims success in celiac study; BioMarin, Ascendis settle patent disputeBioPharma Dive